Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production
Autor: | Sajadi, A., Bauer, M., Thony, B., Aebischer, P. |
---|---|
Předmět: |
Tyrosine 3-Monooxygenase/metabolism
Corpus Striatum/drug effects/ metabolism/pathology/physiopathology Genetic Vectors Dose-Response Relationship Membrane Transport Proteins/metabolism Vesicular Biogenic Amine Transport Proteins Animals Glial Cell Line-Derived Neurotrophic Factor Parkinson Disease/drug therapy/ metabolism/pathology Presynaptic Terminals/drug effects/metabolism urogenital system Animal Gene Expression Regulation/physiology Lentivirus/genetics Gene Transfer Techniques Membrane Glycoproteins/metabolism Nerve Growth Factors/ biosynthesis/genetics Down-Regulation/genetics Biopterin/ analogs & derivatives/biosynthesis/ metabolism Rats Neural Pathways/metabolism/physiopathology nervous system Substantia Nigra/drug effects/ metabolism/pathology Disease Models GTP Cyclohydrolase/metabolism Female Dopamine/ metabolism Sprague-Dawley Drug |
Popis: | Parkinson's disease (PD) is characterized by the progressive degeneration of the nigrostriatal dopaminergic system. Brain delivery of glial cell line-derived neurotrophic factor (GDNF) has been shown to protect and restore the dopaminergic pathway in various animal models of PD. However, GDNF overexpression in the dopaminergic pathway leads to a time-dependent down-regulation of tyrosine hydroxylase (TH), a key enzyme in dopamine synthesis. In order to elucidate GDNF-mediated biochemical effects on dopaminergic neurons, we overexpressed GDNF in the intact rat striatum using a lentiviral vector-mediated gene transfer technique. Long-term GDNF overexpression led to increased GTP cyclohydrolase I (GTPCH I) activity and tetrahydrobiopterin (BH4) levels. Further, we observed a down-regulation of TH enzyme activity in morphologically intact striatal dopaminergic nerve terminals, as well as a significant decrease of dopamine levels in striatal tissue samples. These results indicate that long-term GDNF delivery is a major factor affecting dopamine biosynthesis via a direct or indirect modulation of TH and GTPCH I and further underscore the importance of assessing both GDNF dose and delivery duration prior to clinical application in order to circumvent potentially adverse pharmacological effects on the biosynthesis of dopamine. |
Databáze: | OpenAIRE |
Externí odkaz: |